This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Novartis Ag. Active years: 2006-2008.
Company Filing History:
Years Active: 2006-2008
Title: Bastian Hengerer: Innovator in Pharmaceutical Compounds
Introduction
Bastian Hengerer is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 2 patents, Hengerer continues to push the boundaries of scientific research and development.
Latest Patents
Hengerer's latest patents include "Heterocyclic compounds useful as Nurr-1 activators." This invention relates to compounds of a specific formula that have various applications in pharmaceuticals. The compounds are designed to activate Nurr-1, which is crucial for certain biological processes. Another significant patent is for "Isoxazolopyridinones," which provides compounds that are also useful as pharmaceuticals. These inventions showcase Hengerer's expertise in creating valuable chemical compounds for medical use.
Career Highlights
Bastian Hengerer is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other talented professionals in the field. Hengerer's contributions to pharmaceutical research have been recognized within the industry, highlighting his role as an innovator.
Collaborations
Hengerer has worked alongside notable colleagues such as Samuel Hintermann and Boris Schmidt. These collaborations have further enhanced the development of his innovative compounds and have contributed to the success of his projects.
Conclusion
Bastian Hengerer is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to medical science. His work continues to impact the field positively, paving the way for future advancements in pharmaceuticals.